Hemophilia: Pathophysiology, Diagnosis and Treatment

Authors

  • Roberta Truzzi COLOMBO Faculdade Ingá - Uningá - Maringá, Brasil
  • Gerson ZANUSSO JÚNIOR Faculdade Ingá - Uningá - Maringá, Brasil

DOI:

https://doi.org/10.14450/2318-9312.v25.e3.a2013.pp155-162

Keywords:

Hemophilia, diagnosis, coagulation factors, treatment

Abstract

Hemophilia is a serious hereditary blood coagulation disorder caused by a deficiency of clotting activity of factor VIII (hemophilia A) or IX (hemophilia B). The disease is caused by alterations in the coding genes of these factors located on the long arm of the sex chromosome X. Thus its occurrence in males is almost exclusive due to the man’s presenting only one X chromosome. The severity of the disease can vary from severe, mild and moderately severe after dosage of the factors VIII and IX clotting. One of the most feared complications of patients with this disease refers to the development of inhibitors that are antibodies directed against the factors infused. The diagnosis is made through laboratory tests, mainly by coagulation profile and serum specific factors, based on the clinical manifestations of the patient. Hemophilia is not curable, and the basis of its treatment is the infusion of the deficient factor concentrate. However, patients may develop specific inhibitors to the factors infused and in these cases the treatment alternatives are the use of biotechnology to new drugs and the use of gene therapy.

Downloads

Published

2013-09-30

How to Cite

COLOMBO, R. T., & ZANUSSO JÚNIOR, G. (2013). Hemophilia: Pathophysiology, Diagnosis and Treatment. Infarma - Pharmaceutical Sciences, 25(3), 155–162. https://doi.org/10.14450/2318-9312.v25.e3.a2013.pp155-162

Issue

Vol. 25 No. 3 (2013)

Section

Review Article

License

Authors who publish in this journal agree to the following terms:

 

  1. Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
  2. Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
  3. Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).